SEC Form 4 · accession 0001104659-18-041954
Nabriva Therapeutics plc · NBRV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Schranz
Officer — Chief Medical Officer
Period of report
Jun 22, 2018
Accepted (ET)
Jun 25, 2018 · 9:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001641640
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 22, 2018 | P | 5,500 | $3.73 | A | 5,500 | D |
Table II — derivative securities
No Table II lines on this filing.